Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

PHASE4RecruitingINTERVENTIONAL
Enrollment

734

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

September 30, 2026

Conditions
Carbapenem Resistant Bacterial InfectionAcinetobacter BacteremiaAcinetobacter Pneumonia
Interventions
DRUG

Cefiderocol

Test drug regimen

DRUG

Ampicillin-sulbactam

Synergistic combination

DRUG

Colistin

Historical comparator

DRUG

Meropenem

Historical comparator synergistic combination

Trial Locations (3)

Unknown

RECRUITING

Rambam Health Care Campus, Haifa

RECRUITING

Sheba Tel HaShomer Medical Campus, Ramat Gan

RECRUITING

Shamir Medical Center (Assaf Harofeh), Tel Aviv

All Listed Sponsors
collaborator

Monaldi Hospital

OTHER

collaborator

Rutgers Robert Wood Johnson Medical School

OTHER

collaborator

Pisa University Hospital

UNKNOWN

collaborator

Assaf-Harofeh Medical Center

OTHER_GOV

collaborator

Sheba Medical Center

OTHER_GOV

lead

Rambam Health Care Campus

OTHER